Seres Therapeutics Inc NASDAQ NMS - GLOBAL MARKET:MCRB
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-09-30 · prior 2025-06-30.
New Positions(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 238,269 | +238,269 | $822.7K | +$822.7K | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 834,107 | +834,107 | $584.0K | +$584.0K | — |
| Royal Bank of Canada | 4,444 | +4,444 | $3.0K | +$3.0K | — |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 0 | -74,629 | $0 | -$52.2K | — |
| DEUTSCHE BANK AG\ | 0 | -6,203 | $0 | -$4.8K | — |
| ADVISOR GROUP HOLDINGS, INC. | 0 | -160 | $0 | -$132 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-09-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 238,269 | $822.7K | +238,269 | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 834,107 | $584.0K | +834,107 | — |
| Royal Bank of Canada | 4,444 | $3.0K | +4,444 | — |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for MCRB against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.